EP3681500
Notkun á pílókarpínhýdróklóríði til að meðhöndla ellifjarsýni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
24.4.2019EP published:
23.3.2022EP application number:
19729883.9
EP translation filed:
14.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
23.4.2039Expiry date:
23.4.2025
Title in English:
USE OF PILOCARPINE HYDROCHLORIDE FOR THE TREATMENT OF PRESBYOPIALanguage of the patent:
English
Timeline
Today
24.4.2019EP application
23.3.2022EP Publication
14.6.2022Translation submitted
15.7.2022Registration published
23.4.2025Expires
Owner
Name:
Allergan, Inc.Address:
2525 Dupont Drive, Irvine, California 92612, US
Inventor
Name:
ROBINSON, Michael, R.Address:
Huntington Beach, California 92606, US
Name:
DIBAS, MohammedAddress:
Corona, California 92883, US
Name:
GIYANANI, JayaAddress:
Irvine, California 92612, US
Name:
GORE, AnuradhaAddress:
Aliso Viejo, California 92656, US
Name:
LEE, SungwookAddress:
Orange, California 92869, US
Name:
LIU, HaixiaAddress:
Irvine, California 92620, US
Name:
MORGAN, AileenAddress:
Rancho Santa Margarita, California 92688, US
Name:
ZHOU, JihaoAddress:
Rancho Santa Margarita, California 92688, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862662144 PDate:
24.4.2018Country:
US
Number:
201862780117 PDate:
14.12.2018Country:
US
Number:
201962790957 PDate:
10.1.2019Country:
US
Classification
Categories:
A61K 31/4178, A61K 9/08, A61P 27/10, A61P 27/02, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 12.7.2022
Expires: 23.4.2023
Payer: Árnason Faktor ehf.
Number: 5
Paid: 21.3.2023
Expires: 23.4.2024
Payer: Árnason Faktor ehf.
Number: 5
Paid: 21.3.2023
Expires: 23.4.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 19.3.2024
Expires: 23.4.2025
Payer: Árnason Faktor ehf.